NGLFINE vs WINDLAS: Stock Comparison
NGL Fine-Chem Limited vs Windlas Biotech Ltd
Live data: 22 July 2026, 3:01 PM IST • Source: NSE and company filings
NGL Fine-Chem Limited is the larger company by market capitalisation. NGL Fine-Chem Limited shows a higher ROE, faster revenue growth and a higher ROCE, while Windlas Biotech Ltd shows a lower P/E, a higher dividend yield and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Side-by-side comparison of NGL Fine-Chem Limited and Windlas Biotech Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | NGLFINE | WINDLAS |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceuticals | Pharmaceuticals |
Price
| Metric | NGLFINE | WINDLAS |
|---|---|---|
| Live Price | ₹3,264.8 | ₹870 |
| Day Change | 0.85% | -1.19% |
| Volume | 5,412 | 33,221 |
| 52-Week High | ₹3,329 | ₹1,097.9 |
| 52-Week Low | ₹1,175.5 | ₹697.4 |
| Distance from 52W High | -1.93% | -20.76% |
Valuation
| Metric | NGLFINE | WINDLAS |
|---|---|---|
| Market Cap | ₹2,008 Cr | ₹1,804 Cr |
| P/E Ratio | 41.23x | 28x |
| P/B Ratio | 6.03x | 3.2x |
| EPS | ₹78.04 | ₹31.5 |
| Book Value | ₹532.95 | ₹275 |
| Dividend Yield | 0.05% | 0.72% |
Growth
| Metric | NGLFINE | WINDLAS |
|---|---|---|
| Revenue Growth (TTM YoY) | 57.2% | 17.7% |
| EPS Growth (TTM YoY) | 1,539.8% | -2.6% |
| Qtr Sales Growth | 57.1% | 17.7% |
| Qtr Profit Growth | 2,398% | -1.78% |
Profitability & Leverage
| Metric | NGLFINE | WINDLAS |
|---|---|---|
| ROE | 15.7% | 12.2% |
| ROCE | 17% | 15.9% |
| Net Margin | 9.59% | 7.35% |
| Operating Margin | 14.5% | 11.6% |
| Debt to Equity | 0.33x | 0.06x |
Shareholding
As of Mar 2026 • change vs previous quarter| Metric | NGLFINE | WINDLAS |
|---|---|---|
| Promoter Holding | 72.74% | 63.31%▲ 1.41 pp |
| FII Holding | 0.03%▲ 0.03 pp | 2.04%▲ 1.44 pp |
| DII Holding | 0% | 9.84%▼ 1.97 pp |
| Public Holding | 27.24%▼ 0.02 pp | 24.8%▼ 0.9 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: NGL Fine-Chem Limited and Windlas Biotech Ltd.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.